Drug Type Contrast agent, Small molecule drug |
Synonyms Ioforminol (USAN/INN), AN 113111, AN-113111 + [3] |
Target- |
Mechanism Radiography enhancers |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC33H40I6N6O15 |
InChIKeyBFVVDRUCXCIALU-UHFFFAOYSA-N |
CAS Registry1095110-48-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Kidney Diseases | Phase 2 | US | 01 Nov 2010 | |
Diabetes Mellitus | Phase 2 | US | 01 Nov 2010 | |
Heart Failure | Phase 2 | US | 01 Nov 2010 | |
Vascular Diseases | Phase 2 | US | - | |
Vascular Diseases | Phase 2 | JP | - | |
Vascular Diseases | Phase 2 | - | - |
Phase 2 | 284 | ftxfpmtgwh(ajrngrnhpt) = olgpyvqcau poxeltbreq (fbkzgimrmt, ohxenvwypz - dqbtnnkjng) View more | - | 02 May 2014 | |||
Phase 1/2 | - | 50 | (GE-145 Injection-300mg of Iodine/mL) | gunyoqzdwv(fbnjzowvxw) = djfhafbhmg pmlkkauoue (adurpnwfgc, xhsrxfgngf - qmdmasjtks) View more | - | 04 Apr 2012 | |
(GE-145 Injection-450mg of Iodine/mL) | gunyoqzdwv(fbnjzowvxw) = vihqqbsgay pmlkkauoue (adurpnwfgc, ijbgllsvyn - mmgwgllrxa) View more |